SCHEMBL2372059

SCHEMBL2372059

CCC1(C)CNCC[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9851980 0.74
SCHEMBL6582235 0.71
SCHEMBL194227 0.70
SCHEMBL2486825 0.70 BACE1 (0.38)
SCHEMBL26492319 0.62 KDM4E (0.39)
SCHEMBL1967252 0.62
SCHEMBL9169515 0.60
SCHEMBL6379784 0.60
SCHEMBL6024634 0.60 SOS1 (0.31)
SCHEMBL17177200 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547661-A2 INDAZOLE COMPOUNDS AND THEIR USES Dana-Farber Cancer Institute, Inc. (US) 2013-01-23 EP disclosed
WO-2011115725-A2 INDAZOLE COMPOUNDS AND THEIR USES DANA-FARBER CANCER INSTITUTE, INC. (US) 2011-09-22 WO disclosed
EP-1539754-A4 BENZIMIDAZOLE QUINOLINONES AND USES THEREOF NOVARTIS VACCINES & DIAGNOSTIC (US) 2009-02-25 EP disclosed
EP-1539754-A2 BENZIMIDAZOLE QUINOLINONES AND USES THEREOF Chiron Corporation (US) 2005-06-15 EP disclosed
WO-2004018419-A2 BENZIMIDAZOLE QUINOLINONES AND USES THEREOF CHIRON CORPORATION (US) 2004-03-04 WO disclosed